Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets

被引:33
作者
Fenjves, ES [1 ]
Ochoa, MS [1 ]
Gay-Rabinstein, C [1 ]
Molano, RD [1 ]
Pileggi, A [1 ]
Mendez, AJ [1 ]
Inverardi, L [1 ]
Ricordi, C [1 ]
机构
[1] Univ Miami, Sch Med, Diabet Res Inst, Miami, FL 33136 USA
关键词
D O I
10.1097/01.TP.0000110422.27977.26
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The transfer of cytoprotective genes to isolated pancreatic islets may contribute to their enhanced survival in the transplant setting. Our laboratory established the expression of functional erythropoietin (EPO) receptors throughout pancreatic islets. Because EPO is a cytokine that promotes survival, we examined whether adenovirus-mediated gene transfer of EPO would result in cytoprotection of human pancreatic islets in culture and in the transplant setting. Methods. Isolated human islets were transduced using an adenoviral vector coding for human EPO or green fluorescent protein. Comparison of cell death in culture was measured using annexin V-phycoerythrin and propidium iodide. Transplantation of transduced islets into diabetic nude mice was used to assess the effect of EPO on islet function an din vivo survival. Results. Adenoviral delivery of EPO to pancreatic islets resulted in high-level EPO synthesis and secretion, which did not affect islet function in vitro or in vivo. Islets transduced with EPO were protected from apoptosis in culture and were at a functional advantage in vivo when compared with islets transduced with green fluorescent protein or untransduced islets. The high level of EPO had a negative effect on the blood chemistry of the animals that underwent transplantation. Conclusions. Overexpression of EPO protects islets from destruction and does not compromise islet function. Genetic engineering with EPO may be a viable approach for improving islet survival and engraftment in the transplant setting, but regulation of the gene's expression will be an important prerequisite to this strategy.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 29 条
[1]   β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia [J].
Biarnés, M ;
Montolio, M ;
Nacher, V ;
Raurell, M ;
Soler, J ;
Montanya, E .
DIABETES, 2002, 51 (01) :66-72
[2]   Activation of STAT5 during EPO-directed suppression of apoptosis [J].
Bittorf, T ;
Seiler, J ;
Lüdtke, B ;
Büchse, T ;
Jaster, R ;
Brock, J .
CELLULAR SIGNALLING, 2000, 12 (01) :23-30
[3]   Overexpression of parathyroid hormone-related protein inhibits pancreatic β-cell death in vivo and in vitro [J].
Cebrian, A ;
García-Ocaña, A ;
Takane, KK ;
Sipula, D ;
Stewart, AF ;
Vasavada, RC .
DIABETES, 2002, 51 (10) :3003-3013
[4]   Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury [J].
Celik, M ;
Gökmen, N ;
Erbayraktar, S ;
Akhisaroglu, M ;
Konakç, S ;
Ulukus, C ;
Genc, S ;
Genc, K ;
Sagiroglu, E ;
Cerami, A ;
Brines, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2258-2263
[5]   Beyond erythropoiesis: Novel applications for recombinant human erythropoietin [J].
Cerami, A .
SEMINARS IN HEMATOLOGY, 2001, 38 (03) :33-39
[6]  
CONTRERAS JL, 2002, KIDNEY INT S1, V61, P79
[7]   Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors [J].
Fenjves, ES ;
Ochoa, MS ;
Cabrera, O ;
Mendez, AJ ;
Kenyon, NS ;
Inverardi, L ;
Ricordi, C .
TRANSPLANTATION, 2003, 75 (08) :1356-1360
[8]  
GARCIA OCANA A, 2003, J BIOL CHEM, V278, P343
[9]   Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I [J].
Giannoukakis, N ;
Mi, Z ;
Rudert, WA ;
Gambotto, A ;
Trucco, M ;
Robbins, P .
GENE THERAPY, 2000, 7 (23) :2015-2022
[10]   Infection of intact human islets by a lentiviral vector [J].
Giannoukakis, N ;
Mi, Z ;
Gambotto, A ;
Eramo, A ;
Ricordi, C ;
Trucco, M ;
Robbins, PD .
GENE THERAPY, 1999, 6 (09) :1545-1551